Vertex Pharma News, Vertex Pharma Quote, VRTX Quote

Vertex Pharma (NQ:VRTX) Delayed: 399.78 -5.13 (1.27%)

Prev. Close

$404.91

Open

$404.50

52 Wk High

$134.71

52 Wk Low

$73.31

Day High

$406.83

Day Low

$399.37

P/E

N/A

EPS

$-1.98

Volume

302,237

Friends, Peers and Foes (?): VTECF, AA3, CRSP, ALPN, JPM (more...)

Apr 23, 2024 12:45 AM VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Apr 18, 2024 08:03 AM Vertex Pharma (VRTX) Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Apr 18, 2024 08:00 AM Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Apr 17, 2024 04:08 PM Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: SACHS BRUCE I
Apr 17, 2024 08:14 AM Vertex (VRTX) PT Lowered to $466 at UBS
Apr 16, 2024 04:57 PM Form PX14A6G VERTEX PHARMACEUTICALS Filed by: Arjuna Capital
Apr 16, 2024 01:15 PM Vertex (VRTX) PT Raised to $450 at Guggenheim
Apr 16, 2024 08:02 AM Vortex Energy Corp. Sends Core Samples from the Robinsons River Salt Project to the University of Alberta
Apr 15, 2024 04:48 PM Truist Securities Assumes Vertex (VRTX) at Buy
Apr 11, 2024 08:12 AM Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall

Entities mentioned with VRTX